Kura Oncology (KURA) stock Forecast for 2021 – 2025

Kura Oncology (KURA) stock Forecast for 2022 – 2026

Last update: November 26, 2022 (17:07)

Sector: Healthcare

The share price of Kura Oncology, Inc. (KURA) now

What analysts predict: $32.33

52-week high/low: $19.93 / $10.41

50/200 Day Moving Average: $14.59 / $15.01

This figure corresponds to the average price over the previous 50/200 days. For Kura Oncology stocks, the 50-day moving average is the support level today.

For Kura Oncology stocks, the 200-day moving average is the resistance level today.

Are you interested in Kura Oncology, Inc. stocks and want to buy them, or are they already in your portfolio? If yes, then on this page you will find useful information about the dynamics of the Kura Oncology stock price in 2022, 2023, 2024, 2025, 2026. How much will one Kura Oncology share be worth in 2022 - 2026?

When should I take profit in Kura Oncology stock? When should I record a loss on Kura Oncology stock? What are analysts' forecasts for Kura Oncology stock? What is the future of Kura Oncology stock? We forecast Kura Oncology stock performance using neural networks based on historical data on Kura Oncology stocks. Also, when forecasting, technical analysis tools are used, world geopolitical and news factors are taken into account.

Kura Oncology stock prediction results are shown below and presented in the form of graphs, tables and text information, divided into time intervals. (Next month, 2022, 2023, 2024, 2025 and 2026) The final quotes of the instrument at the close of the previous trading day are a signal to adjust the forecasts for Kura Oncology shares. This happens once a day.




Historical and forecast chart of Kura Oncology stock

The chart below shows the historical price of Kura Oncology stock and a prediction chart for the next month. For convenience, prices are divided by color. Forecast prices include: Optimistic Forecast, Pessimistic Forecast, and Weighted Average Best Forecast. Detailed values for the Kura Oncology stock price can be found in the table below.

Long-term forecasts by years.

Kura Oncology daily forecast for a month

Date Target Pes. Opt. Vol., %
Nov 28 15.03 14.82 15.17 2.31
Nov 29 15.13 14.88 15.39 3.46
Nov 30 15.10 14.88 15.28 2.66
Dec 01 15.07 14.85 15.16 2.08
Dec 02 14.97 14.68 15.27 4.00
Dec 03 15.34 15.10 15.62 3.48
Dec 04 15.33 15.21 15.43 1.44
Dec 05 15.38 15.14 15.67 3.50
Dec 06 15.08 14.83 15.20 2.49
Dec 07 15.05 14.80 15.27 3.20
Dec 08 14.89 14.74 15.11 2.50
Dec 09 15.05 14.89 15.22 2.25
Dec 10 14.92 14.71 15.15 3.04
Dec 11 15.05 14.77 15.13 2.47
Dec 12 14.91 14.71 15.14 2.94
Dec 13 15.16 14.91 15.45 3.61
Dec 14 15.50 15.22 15.62 2.62
Dec 15 15.42 15.14 15.72 3.82
Dec 16 15.38 15.23 15.69 3.03
Dec 17 15.04 14.81 15.22 2.74
Dec 18 15.20 14.90 15.45 3.65
Dec 19 15.02 14.77 15.28 3.41
Dec 20 15.14 15.00 15.30 1.99
Dec 21 15.03 14.91 15.31 2.67
Dec 22 15.13 15.02 15.27 1.66
Dec 23 15.41 15.18 15.63 2.97
Dec 24 15.07 14.92 15.28 2.42
Dec 25 14.93 14.84 15.09 1.71
Dec 26 14.88 14.60 14.96 2.45
Dec 27 14.92 14.63 15.08 3.14

Kura Oncology Daily Price Targets


Kura Oncology Stock Forecast 11-28-2022.

Forecast target price for 11-28-2022: $15.03.
Positive dynamics for Kura Oncology shares will prevail with possible volatility of 2.255%.
Pessimistic target level: 14.82
Optimistic target level: 15.17

Kura Oncology Stock Forecast 11-29-2022.

Forecast target price for 11-29-2022: $15.13.
Positive dynamics for Kura Oncology shares will prevail with possible volatility of 3.342%.
Pessimistic target level: 14.88
Optimistic target level: 15.39

Kura Oncology Stock Forecast 11-30-2022.

Forecast target price for 11-30-2022: $15.10.
Negative dynamics for Kura Oncology shares will prevail with possible volatility of 2.594%.
Pessimistic target level: 14.88
Optimistic target level: 15.28

Kura Oncology Stock Forecast 12-01-2022.

Forecast target price for 12-01-2022: $15.07.
Negative dynamics for Kura Oncology shares will prevail with possible volatility of 2.038%.
Pessimistic target level: 14.85
Optimistic target level: 15.16

Kura Oncology Stock Forecast 12-02-2022.

Forecast target price for 12-02-2022: $14.97.
Negative dynamics for Kura Oncology shares will prevail with possible volatility of 3.848%.
Pessimistic target level: 14.68
Optimistic target level: 15.27

Kura Oncology Stock Forecast 12-03-2022.

Forecast target price for 12-03-2022: $15.34.
Positive dynamics for Kura Oncology shares will prevail with possible volatility of 3.363%.
Pessimistic target level: 15.10
Optimistic target level: 15.62

KURA (KURA) Monthly Stock Prediction for 2022

Month Target Pes. Opt. Vol., %
Dec. 15.82 15.14 16.74 9.58

Kura Oncology forecast for this year


Kura Oncology Stock Prediction for Dec 2022

An uptrend is forecast for this month with an optimal target price of $15.8186. Pessimistic: $15.14. Optimistic: $16.74



Kura Oncology (KURA) Monthly Stock Prediction for 2023

Month Target Pes. Opt. Vol., %
Jan 15.63 15.00 16.08 6.70
Feb 16.61 15.51 17.65 12.11
Mar 14.88 13.97 15.40 9.29
Apr 14.61 13.32 15.85 15.94
May 14.78 14.34 15.90 9.79
Jun 15.15 13.99 16.43 14.86
Jul 15.93 15.38 17.30 11.13
Aug 16.33 15.78 18.01 12.38
Sep 18.17 16.95 18.72 9.47
Oct 19.14 18.22 20.96 13.06
Nov 17.20 16.22 17.94 9.60
Dec 19.01 18.12 19.88 8.83

Kura Oncology (KURA) Monthly Stock Prediction for 2024

Month Target Pes. Opt. Vol., %
Jan 20.79 20.14 22.09 8.81
Feb 21.23 19.02 22.72 16.28
Mar 20.21 18.42 21.75 15.33
Apr 22.75 21.04 24.68 14.74
May 23.85 23.23 24.62 5.67
Jun 23.75 21.50 25.92 17.04
Jul 23.38 22.29 24.02 7.21
Aug 24.11 23.02 24.80 7.20
Sep 23.08 21.07 24.34 13.44
Oct 20.98 19.42 21.88 11.22
Nov 20.05 18.25 21.46 14.94
Dec 19.30 18.79 20.25 7.19

Kura Oncology (KURA) Monthly Stock Prediction for 2025

Month Target Pes. Opt. Vol., %
Jan 19.47 18.69 20.89 10.54
Feb 18.76 17.62 19.81 11.08
Mar 17.37 16.20 18.00 10.03
Apr 18.28 16.42 19.77 16.94
May 16.07 14.52 17.49 16.96
Jun 16.15 15.14 17.66 14.26
Jul 15.83 14.74 16.35 9.82
Aug 15.46 14.66 16.65 11.95
Sep 14.64 13.67 15.99 14.52
Oct 14.15 13.13 14.83 11.41
Nov 13.23 12.31 13.67 9.93
Dec 13.74 13.04 14.26 8.52

Kura Oncology (KURA) Monthly Stock Prediction for 2026

Month Target Pes. Opt. Vol., %
Jan 14.85 13.83 15.60 11.38
Feb 16.08 14.96 17.59 14.98
Mar 16.06 15.40 17.36 11.31
Apr 15.71 14.71 16.75 12.19
May 14.69 14.27 15.91 10.32
Jun 15.58 14.77 16.96 12.90
Jul 14.63 13.64 15.93 14.33
Aug 15.32 14.54 15.87 8.40
Sep 16.17 15.58 17.37 10.29
Oct 16.78 15.54 18.33 15.23
Nov 17.96 16.68 18.64 10.52
Dec 17.91 16.05 18.94 15.25

Kura Oncology information and performance

Kura Oncology, Inc. operates as a clinical-stage biopharmaceutical company which engages in the research and development of medicines for the treatment of cancer. Its pipeline includes Tipifarnib which is a Farnesyl transferase inhibitor for HRAS Mutant Solid Tumors, Chronic Myelomonocytic Leukemia; KO-947 which is an ERK inhibitor for MAPK Pathway Tumors; and KO-539 which is a Menin MLL inhibitor for acute leukemias. The company was founded by Troy E. Wilson, Yi Liu, Pingda Ren and Antonio Gualberto on August 22, 2014 and is headquartered in La Jolla, CA.

Kura Oncology Address

3033 SCIENCE PARK ROAD, SUITE 220, SAN DIEGO, CA, US

Market Capitalization: 1 026 200 000 $

Market capitalization is the total market value of all issued shares of a company. It is calculated by the formula multiplying the number of shares in the company outstanding by the market price of one share.

EBITDA: -137 028 000 $

EBITDA is earnings before interest, income tax and depreciation of assets.

PE Ratio: None

P/E ratio (price to earnings) - shows the ratio between the price of a share and the company's profit

PEG Ratio: N/A

Price/earnings to growth

DPS: N/A

Dividend Per Share is a financial indicator equal to the ratio of the company's net profit available for distribution to the annual average of ordinary shares.

DY: N/A

Dividend yield is a ratio that shows how much a company pays in dividends each year at the stock price.

EPS: -1.99

EPS shows how much of the net profit is accounted for by the common share.

Quarterly Earnings Growth YOY: N/A
Quarterly Revenue Growth YOY: N/A
Trailing PE: -

Trailing P/E depends on what has already been done. It uses the current share price and divides it by the total earnings per share for the last 12 months.

Forward PE: -

Forward P/E uses projections of future earnings instead of final numbers.

EV To Revenue: -

Enterprise Value (EV) /Revenue

EV To EBITDA: -4.491

The EV / EBITDA ratio shows the ratio of the cost (EV) to its profit before tax, interest and amortization (EBITDA).

Shares Outstanding: 66897000

Number of issued ordinary shares

Shares Float: N/A

Number of freely tradable shares

Shares Short Prior Month: N/A

Shares Short Prior Month - the number of shares in short positions in the last month.

Short Ratio: N/A
Percent Insiders: N/A
Percent Institutions: N/A



Related stocks from Healthcare sector


Disclaimer:

All forecast data on the site are provided for informational purposes of using neural forecasting tools in the financial market and are not a call to action and, moreover, are not trading signals. When using the forecast data, the investor assumes all financial risks. The pandaforecast.com portal is not responsible for the loss of your money in the stock market as a result of using the information contained on the site.